Drug Profile
Heparin - Pfizer
Alternative Names: Heparin sodium - PfizerLatest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anti-infectives; Anti-inflammatories; Antithrombotics; Bronchodilators; Heparins; Mucolytics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Disseminated intravascular coagulation; Peripheral arterial occlusive disorders; Pulmonary embolism; Thromboembolism; Venous thrombosis